1. Scientific Information Requiring a Confidential Agreement
There is important scientific information on LMP400 and LMP744f in GBM and multiple other brain tumors in our approved FDA Orphan Drug Designation filings which can be obtained under a confidentiality agreement.
There are extensive studies done on LMP744 and LMP400 in brain tumors by both the NIH and Gibson Oncology, which are awaiting publication and can be viewed under a confidentiality agreement.
Our Scientific Publications
2. Special Features of Indenoisoquinolines as Top1 and cMYC Agents
4. Indenos cross the Blood Brain Barrier and Maintain High Levels in the Brain for Many Hours
Gibson Oncology has documentation about Indenoisoquinolines crossing the blood brain barrier both in the approved Orphan Drug Designation applications and in proprietary data that can be shared under a confidentiality agreement.
